# A Phase 2a Study Evaluating the Safety and Efficacy of ABT-981 in Patients With Erosive Hand Osteoarthritis

> **NCT02384538** · PHASE2 · COMPLETED · sponsor: **AbbVie** · enrollment: 132 (actual)

## Conditions studied

- Erosive Hand Osteoarthritis

## Interventions

- **BIOLOGICAL:** ABT-981
- **BIOLOGICAL:** Placebo for ABT-981

## Key facts

- **NCT ID:** NCT02384538
- **Lead sponsor:** AbbVie
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-03
- **Primary completion:** 2016-07
- **Final completion:** 2016-07
- **Target enrollment:** 132 (ACTUAL)
- **Last updated:** 2017-08-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02384538

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02384538, "A Phase 2a Study Evaluating the Safety and Efficacy of ABT-981 in Patients With Erosive Hand Osteoarthritis". Retrieved via AI Analytics 2026-08-17 from https://api.ai-analytics.org/clinical/NCT02384538. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*